X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

EYPT

Closed

Eyepoint Pharmaceuticals Inc

9.55
+0.14 (+1.49%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 9.41
Day's Range: 8.955 - 9.595
Send
When Written:
 
2.94
EyePoint Pharmaceuticals Inc is a specialty pharmaceutical company that develops and commercializes innovative ophthalmic products. The company's products are designed to treat various eye diseases and disorders, including uveitis, diabetic macular edema, and retinal vein occlusion. EyePoint's products are based on its proprietary bioerodible and sustained-release delivery technologies, which allow for targeted and controlled drug release.

EyePoint Pharmaceuticals was founded in 1987 and is headquartered in Watertown, Massachusetts. The company has a strong pipeline of products in various stages of development, including DEXYCU, YUTIQ, and Durasert. DEXYCU is an FDA-approved treatment for postoperative inflammation following cataract surgery, while YUTIQ is an FDA-approved treatment for non-infectious uveitis affecting the posterior segment of the eye. Durasert is a sustained-release implant designed to treat diabetic macular edema and retinal vein occlusion.

EyePoint Pharmaceuticals has partnerships with several pharmaceutical companies and research institutions, including Bausch Health Companies, Ocumension Therapeutics, and the Wilmer Eye Institute at Johns Hopkins University. The company is committed to improving the lives of patients with eye diseases and disorders through the development of innovative and effective treatments.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X